Moderna Inc
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American […]
Read More
Here’s how U.S. health officials are responding to bird flu in humans after second case
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low. A strain of bird flu called H5N1 has been confirmed […]
Read More
The stock market gets nailed by the Fed, again. Plus, Starbucks’ quiet comeback
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Fed foils stocks : The market […]
Read More
Stocks making the biggest moves midday: Target, Urban Outfitters, Tesla, Shopify and more
Check out the companies making headlines in midday trading: Target — Shares of the retailer pulled back more than 7% after a first-quarter earnings miss , underscored by a 3% year-over-year decline in sales. Analog Devices — Stock in the semiconductor manufacturer surged more than 8% after second-quarter results beat analysts’ estimates. Massachusetts-based Analog reported […]
Read More
Novavax stock jumps 50% as Sanofi offer kicks off turning issue for battling vaccine maker
A vial labelled “Novavax V COVID-19 Vaccine” is witnessed in this illustration taken January 16, 2022. Dado Ruvic | Reuters Shares of Novavax jumped as a lot as 50% on Monday as Wall Road cheered the firm’s new multibillion-dollar offer with French drugmaker Sanofi that sparked a spectacular turnaround for the having difficulties vaccine maker. […]
Read More
Moderna says FDA delayed RSV vaccine approval to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency […]
Read More
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid […]
Read More
Shares producing the major moves midday: Apple, Peloton, Wayfair, Carvana and extra
Check out out the firms creating headlines in midday investing: Apple — Shares ticked up about 2% forward of the Iphone maker’s next-quarter outcomes due after the closing bell. Peloton — Shares dropped 13% after the work out gear business announced Thursday that CEO Barry McCarthy will be stepping down and that the enterprise will […]
Read More
Shares producing the largest premarket moves: Peloton, Carvana, Cigna, Qualcomm and a lot more
Check out out the businesses generating the major moves in premarket buying and selling: Peloton Interactive — Shares climbed 15% immediately after the conditioning business announced CEO Barry McCarthy will step down whilst it seeks a permanent CEO. Peloton also set a restructuring system that will reduce 15% of its staff, or about 400 workforce. […]
Read More
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the company’s cost-cutting efforts took hold and sales of its Covid vaccine, its only commercially available product, topped estimates. The results come as Moderna inches closer to putting another product on the market, which it badly […]
Read More